Amy Xuy, Radiation Oncologist at Memorial Sloan Kettering Cancer Center, shared a post on X:
“Can tumor genomics be used to personalize radiation dose?
Grateful to present results from our phase II trial on dose de-escalated radiation therapy for ATM altered tumors at ASCO2026
Great to see Radiation in the early-phase Precision Oncology space!”
Other articles about ASCO on OncoDaily.
